weight loss drugs

Explore "weight loss drugs" with insightful episodes like "#245 Ozempic. The truth about the side effects and risks of this Magic Pill with Johann Hari", "Ozempic: Is It Scarier Than We Thought?", "The Ozempic economy", "Ozempic and Wegovy: How 2 diabetes medications became the most popular weight-loss drugs" and "The Weight-Loss Drug Revolution, Part 1: Why These Drugs Work So Well" from podcasts like ""The Doctor's Kitchen Podcast", "Science Vs", "Today, Explained", "Most Innovative Companies" and "Plain English with Derek Thompson"" and more!

Episodes (9)

#245 Ozempic. The truth about the side effects and risks of this Magic Pill with Johann Hari

Johann Hari is back on the podcast today and he looks completely different to the last time I saw him. He’s lost an incredible amount of weight, his face looks completely different and it’s all because of a drug you’ve probably already heard of. Ozempic.

Also known as GLP-1 agonists, these drugs were initially used by doctors like myself in General Practice for type 2 diabetics, but have now found a use case to treat obesity.

For over a year, Johann has been self treating with the drugs and diving into the history of how these drugs were discovered and utilised. From the lab to the pharmaceutical companies & the doctors surgery to the popular pages of celebrity gossip columns; Johann tells the full story without shying away from the potentially dangerous reality of the sideffects and risks of these popular medications.

We talk about:

What Ozepmic and similar drugs do to your brain and gut

How it impacts addiction to food and other substances

What the potential risks are including cancer, pancreatitis and bowel obstruction

Why UPF and obesity are the main concern

You can purchase Johann’s newest book, ‘Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight Loss Drugs’, available on 2nd May 2024, here: https://amzn.to/3Ulz2UB

Johann Hari is a New York Times best-selling author, his books include, ‘Chasing the Scream’, ‘Lost Connections’, and ‘Stolen Focus’. He has written for the world’s leading newspapers and magazines, and has twice been named ‘National Newspaper Journalist of the Year’ by Amnesty International.

🎬 Watch the podcast on YouTube here

📱 Download The Doctor’s Kitchen app for free*

🌐 View full show notes, including guest details, on our website

*The Doctor's Kitchen App gives you access to all of our recipes, with specific suggestions tailored to your health needs and new recipes added every month. We’ve had some amazing feedback so far and we have new features being added all the time - check it out with a 14 day free trial too.

Do check out this week’s “Eat, Listen, Read” newsletter, that you can subscribe to on our website - where I send you a recipe to cook as well as some mindfully curated media to help you have a healthier, happier week.

🥗 Join the newsletter and 7 day meal plan

📷 Follow on Instagram

🐦 Tweet me

We would love to get your feedback on the subject matter of these episodes - please do let me know on our social media pages (Instagram, Facebook & Twitter) what you think, and give us a 5* rating on your podcast player if you enjoyed today’s episode

Hosted on Acast. See acast.com/privacy for more information.

The Doctor's Kitchen Podcast

enMay 01, 2024

Ozempic: Is It Scarier Than We Thought?

We looked at this class of weight loss drugs a year ago, and they've only gotten more popular — and more controversial. We’re hearing that these kinds of drugs can be tough on your stomach, and that the weight loss comes with worrisome loss of muscle. We’ve also heard claims that they might increase your risk of suicide. So — should we be freaking out here?? We talk to endocrinologist Dr. Vibha Singhal, neuroscientist Dr. Nora Volkow, and gastroenterologist Dr. Michael Camilleri. This episode does deal with depression and suicidal thoughts. Here are some crisis hotlines: United States: US National Suicide Prevention Lifeline Dial 988 (Online chat available); US Crisis Text Line Text “HOME” to 741741 Australia: Lifeline 13 11 14 (Online chat available) Canada: Canadian Association for Suicide Prevention (See link for phone numbers listed by province) United Kingdom: Samaritans 116 123 (UK and ROI) Full list of international hotlines here Find our transcript here: https://bit.ly/ScienceVsOzempic2Scarier Chapters: In this episode, we cover: (00:00) What are the fears around these weight loss drugs? (04:46) Do these drugs melt your muscles? (11:49) Do these drugs increase the risk of suicidal thoughts? (16:15) Can they really paralyze your stomach? (30:25) Some good news! (33:36) How Did You Find the Bezoar? CREDITS This episode was produced by Rose Rimler, with help from Wendy Zukerman, Meryl Horn, Michelle Dang, and Joel Werner. We’re edited by Blythe Terrell. Fact checking by Erica Akiko Howard. Recording assistance from Selena Seay-Reynolds. Mix and sound design by Bobby Lord and Peter Leonard. Music written by Bumi Hidaka, Emma Munger, Peter Leonard, So Wylie and Bobby Lord. Thanks to all of the researchers we spoke to for this episode, including Dr. Kristen Beavers, Dr. Ellen Fallows, Dr. Joseph Henson, Dr. Dimitrios Papamargaritis, Prof. Roger McIntyre, Prof. Russ Waitman, Dr. Sahib Khalsa,, Dr. Travis Masterson, and Dr. Etienne Wang. Thanks also to Bryant Smith and Lori Segal. And special thanks to the listeners on these medications who checked back in with us. A special thanks to the Zukerman Family and Joseph Lavelle Wilson. Science Vs is a Spotify Studios Original. Listen for free on Spotify or wherever you get your podcasts. Follow us and tap the bell for episode notifications. Learn more about your ad choices. Visit podcastchoices.com/adchoices

enMarch 14, 2024

The Ozempic economy

The weight loss drug is so profitable that its parent company, Danish health care giant Novo Nordisk, is propping up Denmark’s entire economy. It’s poised to transform America’s too. This episode was produced by Victoria Chamberlin edited by Jolie Myers, fact-checked by Kim Eggleston, engineered by Rob Byers, and hosted by Noel King. Transcript at vox.com/todayexplained Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts Learn more about your ad choices. Visit podcastchoices.com/adchoices

enFebruary 23, 2024

Ozempic and Wegovy: How 2 diabetes medications became the most popular weight-loss drugs

In the United States, nearly three-quarters of adults qualify as overweight or obese, 42% of whom are considered obese. The World Obesity Federation predicts that 51% of the global population will be overweight or obese by 2035. ‘Fast Company’ contributing writer Adam Bluestein joined us to break down how Novo Nordisk, the company behind Ozempic and Wegovy, developed and marketed its weight-loss drugs. He also explained why the drugs have become so popular in the U.S., how drug pricing is extremely complicated and . . . how the medications actually work to help people lose weight. Also, we chatted with Trina Spear about how she founded Figs, a DTC healthcare apparel company.

Most Innovative Companies

enDecember 20, 2023

medicare price negotiation

The Weight-Loss Drug Revolution, Part 1: Why These Drugs Work So Well

Today’s podcast is about the weight-loss drug revolution—which I believe might be one of the most important stories in the world right now. Despite all the attention weight-loss drugs are receiving, it’s possible that they might soon affect the world even more than we realize as they teach us about the science of human metabolism, decision-making, and even free will. Beverly Tchang, an endocrinologist at Weill Cornell, explains how these drugs work, what they mean for people with diabetes and obesity, and how to wrap our minds around their stranger and spookier side effects. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guest: Beverly Tchang Producer: Devon Manze Learn more about your ad choices. Visit podcastchoices.com/adchoices

Plain English with Derek Thompson

enDecember 12, 2023

Who can and cannot get weight-loss drugs

Drugs used for weight loss like Wegovy, Ozempic and Mounjaro are nearly everywhere in popular culture, but many patients struggling with obesity are still finding them hard to get. On today's show, what's slowing access to these drugs despite their long-term benefits for the economy and patients, and how social conditioning around obesity and excess weight clouds the conversation.

Related Episodes:
New drugs. Cheaper drugs. Why not both? (Apple / Spotify)

For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.

Music by Drop Electric. Find us: TikTok, Instagram, Facebook, Newsletter.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

The Indicator from Planet Money

en-usDecember 04, 2023

FL Trans Treatment Fines & Homelessness Rises | 8.18.23

Florida becomes the first state to fine healthcare providers for funding transgender treatments for minors, Americans are becoming homeless at a rate that’s never been seen before, and doctors warn about the potentially dangerous side effects associated with weight loss drugs like Ozempic and Wegovy. Get the facts first with Morning Wire.

Black Rifle Coffee: Get 10% off your first order or Coffee Club subscription with code WIRE: https://www.blackriflecoffee.com/

Cynch: Download the Cynch app and get your first tank exchange for just $10 with promo code WIRE. Visit http://cynch.com/offer for details.

enAugust 18, 2023

transgender treatments

The weight-loss drug craze

The UK government is pushing back against an attempt by some members of the House of Lords to close loopholes in transparency legislation, US bank stocks fell after Moody’s cut the credit ratings of 10 midsized banks, and the FT’s Jamie Smyth explains the craze behind new weight-loss drugs.

Mentioned in this podcast:

UK government resists moves to tighten corporate transparency rules

Weak bank stocks weigh on US and European markets

Novo Nordisk’s obesity drug cuts risk of strokes and heart attacks

Orange juice futures hit record high after storms ravage Florida crop

The FT News Briefing is produced by Fiona Symon, Sonja Hutson and Marc Filippino. Additional help from Monica Lopez, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley. The show’s theme song is by Metaphor Music.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

enAugust 09, 2023

Fen Phen & Redux

Fen-Phen & Redux were "the next miracle drugs" in the '90s, claiming to help people lose dramatic amounts of weight in just three months. But within a few short years, they'd been pulled from the market. They were just too effective! (Just kidding, they killed some people.)

Support us:

Links!